Improving sleep in the intensive care unit with a relaxation medicine
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This study tests whether giving a medicine called dexmedetomidine (which helps people relax and sleep) as part of a sleep-promoting routine can reduce confusion and delirium in the intensive care unit (ICU). It may help you sleep better and recover more smoothly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are currently in the intensive care unit (ICU) and expected to stay for at least two more days
- You are on a breathing machine or high-flow oxygen
- You are awake enough to answer questions about your sleep
- You have a stable heart rhythm and blood pressure
- You do not have severe liver or kidney disease, or a serious brain condition like a recent stroke or dementia
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combination of two medicines (dexmedetomidine and esketamine) to help ICU patients who are on a breathing machine feel calm and have less pain. The goal is to find a safe and effective way to keep patients comfortable while they recover.
This study tests two medications, haloperidol and dexmedetomidine, to see which works better for reducing confusion and agitation in patients who are on a breathing machine after a traumatic brain injury. If you or a loved one is in the ICU with a brain injury and is restless or confused, this trial may help find better ways to manage those symptoms.
This study tests whether a medicine called dexmedetomidine, given after heart surgery, can help prevent confusion and thinking problems in older adults during their intensive care stay. If you are 60 or older and having heart surgery with a heart-lung machine, this trial might be for you.
This study looks at how a sleep medicine called dexmedetomidine affects thinking and memory after heart surgery. It compares cognitive outcomes over time to see if this sedation choice changes long-term brain function.
This study tests whether non-drug methods like soothing music, gentle touch, or aromatherapy can help reduce anxiety, improve sleep, and lower the risk of confusion (delirium) in intensive care patients.
This Phase 2 trial tests whether melatonin can reduce delirium, a sudden confusion that can happen in the ICU. If you qualify, you may be given melatonin to see if it improves alertness and comfort during an expected longer ICU stay.
Hear when a new Delirium trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.